BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16461917)

  • 1. S-nitrosothiol depletion in amyotrophic lateral sclerosis.
    Schonhoff CM; Matsuoka M; Tummala H; Johnson MA; Estevéz AG; Wu R; Kamaid A; Ricart KC; Hashimoto Y; Gaston B; Macdonald TL; Xu Z; Mannick JB
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2404-9. PubMed ID: 16461917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis.
    Chen X; Zhang X; Li C; Guan T; Shang H; Cui L; Li XM; Kong J
    J Neurochem; 2013 Jan; 124(1):45-58. PubMed ID: 23043510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
    Turner BJ; Lopes EC; Cheema SS
    J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria.
    Liu J; Lillo C; Jonsson PA; Vande Velde C; Ward CM; Miller TM; Subramaniam JR; Rothstein JD; Marklund S; Andersen PM; Brännström T; Gredal O; Wong PC; Williams DS; Cleveland DW
    Neuron; 2004 Jul; 43(1):5-17. PubMed ID: 15233913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress.
    Cookson MR; Menzies FM; Manning P; Eggett CJ; Figlewicz DA; McNeil CJ; Shaw PJ
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):75-85. PubMed ID: 12215229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis.
    Tokuda E; Ono S; Ishige K; Naganuma A; Ito Y; Suzuki T
    Toxicology; 2007 Jan; 229(1-2):33-41. PubMed ID: 17097207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis.
    Urushitani M; Sik A; Sakurai T; Nukina N; Takahashi R; Julien JP
    Nat Neurosci; 2006 Jan; 9(1):108-18. PubMed ID: 16369483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
    Oh YK; Shin KS; Yuan J; Kang SJ
    J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
    Watanabe S; Nagano S; Duce J; Kiaei M; Li QX; Tucker SM; Tiwari A; Brown RH; Beal MF; Hayward LJ; Culotta VC; Yoshihara S; Sakoda S; Bush AI
    Free Radic Biol Med; 2007 May; 42(10):1534-42. PubMed ID: 17448900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
    Zimmerman MC; Oberley LW; Flanagan SW
    J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.
    Kariya S; Re DB; Jacquier A; Nelson K; Przedborski S; Monani UR
    Hum Mol Genet; 2012 Aug; 21(15):3421-34. PubMed ID: 22581780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
    Gong YH; Elliott JL
    Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS.
    Israelson A; Arbel N; Da Cruz S; Ilieva H; Yamanaka K; Shoshan-Barmatz V; Cleveland DW
    Neuron; 2010 Aug; 67(4):575-87. PubMed ID: 20797535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions.
    Kunst CB; Mezey E; Brownstein MJ; Patterson D
    Nat Genet; 1997 Jan; 15(1):91-4. PubMed ID: 8988176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis.
    Chang-Hong R; Wada M; Koyama S; Kimura H; Arawaka S; Kawanami T; Kurita K; Kadoya T; Aoki M; Itoyama Y; Kato T
    Exp Neurol; 2005 Jul; 194(1):203-11. PubMed ID: 15899257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.